Lymphopenia News and Research

RSS
Lymphopenia is a condition in which there is a lower-than-normal number of lymphocytes (a type of white blood cell) in the blood. Also called lymphocytic leukopenia and lymphocytopenia.
HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

SARS-CoV-2-specific IgM / IgG responses accurately predict COVID-19 outcome

SARS-CoV-2-specific IgM / IgG responses accurately predict COVID-19 outcome

Preliminary analysis of photon therapy treatment group 1 shows no significant differences between arms

Preliminary analysis of photon therapy treatment group 1 shows no significant differences between arms

Characterization of prognostic markers to predict COVID-19 severity

Characterization of prognostic markers to predict COVID-19 severity

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

LOX-1-immature neutrophils may help identify COVID-19 patients at risk of thrombosis complication

LOX-1-immature neutrophils may help identify COVID-19 patients at risk of thrombosis complication

D-dimer - A sensitive novel biomarker of COVID-19 mortality

D-dimer - A sensitive novel biomarker of COVID-19 mortality

Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity

Exponential rise in COVID-19 hospitalization risk with age due to waning T cell immunity

SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19

SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

Targeted therapy achieves durable objective responses Phase I/II LIBRETTO-001 trial

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

Targeting SARS-CoV-2 with off-the-shelf CAR-NK cells

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

Severe fatigue common in COVID-19, independent of disease severity

Severe fatigue common in COVID-19, independent of disease severity

Dysfunctional T cells present at high levels in severe COVID-19

Dysfunctional T cells present at high levels in severe COVID-19

Study: Cellular therapy can improve critical cases of COVID-19

Study: Cellular therapy can improve critical cases of COVID-19

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

HORIBA Medical white paper provides a review of hematology biomarkers for COVID-19 assessment

Immune response variations across the COVID-19 spectrum

Immune response variations across the COVID-19 spectrum

SARS-CoV-2 induces broad T cell response in recovering patients

SARS-CoV-2 induces broad T cell response in recovering patients

Balanced B and T cell response required to control SARS-CoV-2

Balanced B and T cell response required to control SARS-CoV-2